ArticleACS omega2025
The Use of dSTORM-Based Single Exosome Analysis To Study Tetraspanin Abundance in Extracellular Vesicles.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A Rapid, High-Resolution Chromatographic Method for Isolating Subpopulations of HEK293-derived Extracellular Vesicles.Nanotheranostics · 2026Article
- Osteogenic Effects of Brown AlgaePreventive nutrition and food science · 2025Article
- Dendritic Cell-Derived Exosomes: Next Generation of Cancer Immunotherapy.Biomedicines · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Serum-derived exosomes are membrane-enclosed nanovesicles secreted by cells, typically between 30 and 120 nm in diameter. Exosomes can be identified by the presence of tetraspanin protein markers including CD9, CD81, and CD63 among others. The relative amounts of these exosomal markers and their location in the exosomes are also related to their source of origin. The ability to investigate these different markers and their locations in individual and multiple exosomes was obtained using an optical imaging technique known as dSTORM (direct stochastic optical reconstruction microscopy) which can overcome the diffraction limit for detection of these nanovesicles. The use of the dSTORM imaging method has allowed us to evaluate the relative abundance of tetraspanin markers CD9, CD81, and CD63 in exosomes and the size of exosomes related to these markers. We also compared the presence of these markers in normal versus pancreatic cancer serum samples and against exosomes secreted from cell lines. We found that CD9 is generally the most abundant marker in exosomes and is found near the surface of the exosomes, although CD81 and CD63 abundance is also significant. This result is consistent with our prior DIA mass spectrometry data and may be important in future work involving analysis of exosomes as markers of disease.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.